Daré Bioscience, Inc. (DARE)

Daré Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	18.52	24.71	23.08	5.04	10.33	15.7	11.23	16.41	3.63	10.48	13.89	13.33	19.83	34.67	40.39	32.07	39.32	51.67	45.57	9.11
Cash & Short-Term Investments	18.52	24.71	23.08	5.04	10.33	15.7	11.23	16.41	3.63	10.48	13.89	13.33	19.83	34.67	40.39	32.07	39.32	51.67	45.57	9.11
Cash Growth	79.28%	57.42%	105.43%	-69.33%	184.53%	49.85%	-19.16%	23.15%	-81.69%	-69.78%	-65.60%	-58.44%	-49.56%	-32.91%	-11.37%	251.97%	413.26%	1006.64%	745.56%	70.41%
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	-	-	-	-
Other Receivables	0.69	-	0.37	0.19	0.11	-	0.52	0.9	1.39	0.95	1.13	0.57	2.4	1.7	2.29	2.14	1.73	1.15	0.16	2.96
Total Trade Receivables	0.69	-	0.37	0.19	0.11	-	0.52	0.9	1.39	0.95	1.13	0.57	2.4	1.7	2.29	12.14	1.73	1.15	0.16	2.96
Other Current Assets	2.45	2.35	1.56	1.38	1.39	2.75	3.19	3.51	4.97	6.12	7.41	8.34	7.28	6.67	6.89	5.9	6.77	2.48	2.52	1.99
Total Current Assets	21.66	27.06	25	6.6	11.82	18.45	14.95	20.83	9.98	17.54	22.44	22.24	29.51	43.04	49.57	50.11	47.82	55.3	48.24	14.06
Net Property, Plant & Equipment	3.73	4.4	4.73	5.31	5.72	2.54	2.03	1.77	1.61	1.98	0.06	0.05	0.06	0.52	0.07	0.02	0.03	0.03	0.03	0.02
Other Long-Term Assets	2.44	1.01	1.02	1.07	1.08	1.11	1.08	1.01	1.42	1.76	2.56	0.92	0.8	0.26	0.74	1.26	1.34	0.49	0.54	0.74
Total Assets	27.83	32.47	30.75	12.98	18.62	22.1	18.06	23.61	13.01	21.28	25.05	23.21	30.37	43.83	50.38	51.39	49.19	55.81	48.81	14.82
Accounts Payable	1.23	1.2	1.84	1.76	1.88	1.46	1.05	1.91	4.04	3.39	4.99	6.54	2.7	2.03	3.48	1.11	2.83	2.1	0.61	0.22
Accrued Expenses	0.53	0.73	2.32	2.52	1.77	3.04	1.85	1.25	1.37	2.89	5.29	4.19	5.48	10.89	4.14	6.35	3.54	3.14	3.78	4.37
Current Portion of Leases	1.2	2.1	2.48	2.42	2.32	0.55	0.51	0.49	0.47	0.47	0.19	0.27	0.34	0.4	0.39	0.32	0.29	0.27	0.37	0.42
Unearned Revenue	18.15	19.65	14.56	12.33	15.12	16.56	9.75	10.94	11.84	13.74	15.87	13.69	15.83	18.3	14.84	8.75	9.73	10.54	11.16	-
Other Current Liabilities	0.01	0.01	0.01	0.19	0.09	0	-	-	0.01	-	-	-	-	-	-	-	-	-	-	1
Total Current Liabilities	21.12	23.69	21.22	19.22	21.19	21.61	13.16	14.59	17.72	20.48	26.34	24.7	24.34	31.62	22.84	16.54	16.39	16.05	15.91	6
Long-Term Leases	0.42	0.56	0.45	0.61	1.25	0.75	0.9	1.04	1.17	0.94	-	0.02	0.06	0.09	0.19	0.82	0.91	-	0.02	0.07
Other Long-Term Liabilities	5.56	5.39	6.22	5.88	5.74	5.75	5.49	5.31	5.12	4.91	1	1.21	1	1	1	1	1	1	1	1
Total Long-Term Liabilities	5.97	5.95	6.67	6.49	6.99	6.5	6.39	6.34	6.29	5.85	1	1.23	1.06	1.09	1.19	1.82	1.91	1	1.02	1.07
Total Liabilities	27.09	29.63	27.89	25.71	28.18	28.11	19.54	20.93	24.01	26.33	27.34	25.93	25.4	32.71	24.03	18.36	18.31	17.05	16.92	7.08
Common Stock	0	0	0	0	0	0	0	0	0.01	0	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	192.8	191.95	190.5	171.35	170.52	169.71	168.66	168.14	167.38	166.55	164.3	155.56	154.45	152.53	152	151.44	149.56	149.03	132.64	95.76
Accumulated Other Comprehensive Income	-0.38	-0.42	-0.4	-0.4	-0.42	-0.43	-0.36	-0.39	-0.4	-0.36	-0.42	-0.4	-0.37	-0.35	-0.53	-0.3	-0.16	-0.15	-0.17	-0.11
Retained Earnings	-191.69	-188.69	-187.25	-183.68	-179.67	-175.29	-169.78	-165.08	-177.99	-171.24	-166.18	-157.88	-149.12	-141.07	-125.13	-118.11	-118.53	-110.13	-100.58	-87.92
Total Common Shareholders' Equity	0.73	2.84	2.86	-12.73	-9.56	-6.01	-1.48	2.67	-11	-5.05	-2.29	-2.72	4.97	11.11	26.34	33.03	30.88	38.75	31.89	7.74
Shareholders' Equity	0.73	2.84	2.86	-12.73	-9.56	-6.01	-1.48	2.67	-11	-5.05	-2.29	-2.72	4.97	11.11	26.34	33.03	30.88	38.75	31.89	7.74
Total Liabilities & Equity	27.83	32.47	30.75	12.98	18.62	22.1	18.06	23.61	13.01	21.28	25.05	23.21	30.37	43.83	50.38	51.39	49.19	55.81	48.81	14.82
Total Debt	1.61	2.66	2.93	3.03	3.57	1.3	1.4	1.52	1.64	1.4	0.19	0.3	0.39	0.49	0.58	1.15	1.21	0.27	0.38	0.49
Net Cash (Debt)	16.91	22.06	20.14	2	6.76	14.4	9.83	14.89	1.99	9.07	13.7	13.03	19.44	34.18	39.81	30.92	38.11	51.4	45.19	8.62
Net Cash Growth	150.18%	53.21%	104.93%	-86.55%	239.80%	58.68%	-28.26%	14.24%	-89.77%	-73.46%	-65.58%	-57.85%	-49.00%	-33.51%	-11.91%	258.76%	439.49%	1213.79%	897.61%	96.46%
Net Cash Per Share	1.16	1.54	1.58	0.23	0.77	1.79	1.15	1.76	0.24	1.24	1.81	1.81	2.73	4.92	5.63	4.35	5.45	7.71	7.66	2.05
Book Value	0.73	2.84	2.86	-12.73	-9.56	-6.01	-1.48	2.67	-11	-5.05	-2.29	-2.72	4.97	11.11	26.34	33.03	30.88	38.75	31.89	7.74
Book Value Per Share	0.05	0.20	0.22	-1.44	-1.09	-0.75	-0.17	0.32	-1.31	-0.69	-0.30	-0.38	0.70	1.60	3.73	4.64	4.41	5.81	5.41	1.84
Tangible Book Value	0.73	2.84	2.86	-12.73	-9.56	-6.01	-1.48	2.67	-11	-5.05	-2.29	-2.72	4.97	11.11	26.34	33.03	30.88	38.75	31.89	7.74
Tangible Book Value Per Share	0.05	0.20	0.22	-1.44	-1.09	-0.75	-0.17	0.32	-1.31	-0.69	-0.30	-0.38	0.70	1.60	3.73	4.64	4.41	5.81	5.41	1.84

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error